Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-01-22 Director's Dealing
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA: Mandatory notification of trade subscription of shares in rights issue
Director's Dealing Classification · 1% confidence The document is a mandatory notification of trade regarding a subscription of shares in a rights issue by a person discharging managerial responsibilities (PDMR), specifically a board member. While it mentions a rights issue, the core purpose of the filing is to disclose the transaction of shares by an insider (PDMR). Therefore, it falls under the 'Director's Dealing' category.
2026-01-22 English
Lifecare ASA: Preliminary results of the Rights Issue - Attachment: Lifecare ASA- Preliminary results of the Rights Issue.pdf
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Lifecare ASA regarding the preliminary results of a rights issue (a capital raising event). It details the subscription period, the number of shares subscribed, the expected proceeds, and the timeline for final allocation. This falls squarely under the definition of a capital/financing update, as it relates to the company's fundraising activities and capital structure changes.
2026-01-21 English
Lifecare ASA: Preliminary results of the Rights Issue
Share Issue/Capital Change Classification · 1% confidence The document is an announcement regarding the preliminary results of a 'Rights Issue' (a capital raising activity) for Lifecare ASA. It details the subscription period, the number of shares subscribed, and the expected proceeds. This falls under the category of capital and financing updates, specifically related to share issuance and capital structure changes.
2026-01-21 English
Lifecare ASA: Last day of the subscription period for the Rights Issue - Attachment: Lifecare ASA- Last day of the subscription period for the Rights Issue.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Lifecare ASA regarding the expiration of a subscription period for a rights issue (a capital raising event). It provides details on the deadline, subscription procedures, and references the prospectus. Since it is an announcement regarding a capital-raising activity (rights issue) rather than the prospectus itself or a report, it falls under the 'Capital/Financing Update' category.
2026-01-21 English
Lifecare ASA: Last day of the subscription period for the Rights Issue
Capital/Financing Update Classification · 1% confidence The document is an announcement regarding the expiration of a subscription period for a 'Rights Issue' of new shares. It provides instructions for shareholders on how to subscribe and references a previously published prospectus. Since this document is an announcement regarding a capital-raising event (Rights Issue) rather than the prospectus itself or a general regulatory filing, it falls under the 'Share Issue/Capital Change' category.
2026-01-21 English
Lifecare highlights real-world veterinary relevance from ongoing diabetes study - Attachment: Lifecare highlights real-world veterinary relevance from ongoing diabetes study.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Lifecare ASA regarding the progress and preliminary results of a veterinary clinical study (LFC-SEN-002). It provides updates on company research and development activities, which does not fit into specific financial reporting categories like 10-K, ER, or IR. As it is a general corporate announcement regarding operational progress and research milestones, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous corporate news.
2026-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.